In fact, there are more microbes in our gut than there are stars in the Milky Way. These microbes are essential for human ...

Antibiotic-resistant bacterial infections often occur in patients with chronic inflammatory intestinal conditions, such as inflammatory bowel disease, and in patients who have taken antibiotics for a ...

Gut microbiome dynamics reveal key factors influencing Enterobacteriaceae colonization. News-Medical, viewed 09 July 2025, https: ...

IN recent years pathogenic enterobacteriaceae have become increasingly resistant to many antibiotics.§ 1 2 3 Japanese workers showed in 1959 that resistance to multiple antibiotics in many ...

Citing increased reports of carbapenem-resistant Enterobacteriaceae (CRE), the Centers for Disease Control and Prevention (CDC) has expanded guidelines aimed at preventing the spread of these ...

The group of bacteria called Enterobacteriaceae, including Klebsiella pneumoniae, Shigella, E. coli and others, is present at low levels as part of a healthy human gut microbiome. But at high ...

Mortality among patients with infections caused by carbapenem-resistant Enterobacteriaceae (CRE) is high, and such infections have few treatment options. 1,2 We report results from the Combating ...

Carbapenem-resistant Enterobacteriaceae (CRE) are bacteria that are resistant to carbapenem antibiotics. This may make CRE infections hard to treat. Learn more here.

Enterobacteriaceae, a large family of gram-negative bacilli that normally live in the human gastrointestinal tract, are a common cause of both community- and healthcare-acquired infections.

In 2001, only 1.2% of the common family of bacteria, Enterobacteriaceae, were resistant to carbapenem antibiotics — the strongest class available. By 2011, that figure had jumped to 4.2%.